General Information of Drug (ID: DMAD2OZ)

Drug Name
Palovarotene Drug Info
Synonyms R-667; RG-667; Retinoid receptor agonist, Roche; Ro-3300074; Ro-330074
Indication
Disease Entry ICD 11 Status REF
Fibrodysplasia ossificans progressiva FB31.1 Approved [1]
Emphysema CA21 Phase 2 [2]
Cross-matching ID
PubChem CID
10295295
CAS Number
CAS 410528-02-8
TTD Drug ID
DMAD2OZ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [4]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [5]
Trifarotene DMOL793 Acne vulgaris ED80 Approved [6]
Tazarotene DM8SMD1 Acne vulgaris ED80 Approved [7]
PMID27336223-Compound-13 DMSZLYD N. A. N. A. Patented [8]
PMID27336223-Compound-12 DMT4P7K N. A. N. A. Patented [8]
PMID27336223-Compound-14 DMC41MA N. A. N. A. Patented [8]
PMID27336223-Compound-11 DMBN6KU N. A. N. A. Patented [8]
PMID27336223-Compound-15 DMIYCFE N. A. N. A. Patented [8]
PMID27336223-Compound-9 DM6V13W N. A. N. A. Patented [8]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Retinoic acid receptor gamma (RARG) TT1Q3IE RARG_HUMAN Agonist [3]

References

1 FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 215559
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8276).
3 Randomised controlled trial for emphysema with a selective agonist of the gamma-type retinoic acid receptor. Eur Respir J. 2012 Aug;40(2):306-12.
4 Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target. J Med Chem. 2004 Dec 30;47(27):6831-9.
5 Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):30-4.
6 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
7 Recent developments in receptor-selective retinoids. Curr Pharm Des. 2000 Jun;6(9):919-31.
8 Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.Expert Opin Ther Pat. 2016 Aug;26(8):957-71.